• Study of Human Albumin Treatment to Prevent Kidney Dysfunction in Adult Patients After Liver Transplantation

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of levodopa and carbidopa treatment for patients with neurodevelopmental disorder caused by CTNNB1 gene mutation

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of intraperitoneal paclitaxel combined with systemic therapy versus systemic therapy alone for patients with gastric cancer and peritoneal metastases

    Recruiting

    3 1 1 1
    Investigated diseases:
    Italy The Netherlands Norway Sweden
  • A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

    Recruiting

    1 1
    Investigated drugs:
    Belgium Czechia France Germany Greece Italy +5
  • Evaluating kidney cancer aggressiveness using Rubidium Chloride PET scan imaging in patients with renal cell carcinoma

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    France Germany Greece Italy Poland Spain
  • Study of crinecerfont oral solution in children under 2 years old with congenital adrenal hyperplasia to evaluate safety and how the drug works in the body

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy Spain
  • Study of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients

    Recruiting

    2 1 1 1
    Investigated diseases:
    Denmark Germany Norway Spain Sweden
  • Study of tildrakizumab to treat patients with chronic spontaneous urticaria who did not respond to previous treatments

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

powered by